36 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
months, respectively). These results will be presented as a late-breaking abstract at the 2024 American Society of Clinical Oncology (ASCO) Annual … interim long-term data from the Phase 3 EMERGENT program at the Annual Congress of the Schizophrenia International Research Society (SIRS).
◦In the new
8-K
EX-99.1
ZLAB
Zai Lab Limited
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
Society of Medical Oncology Congress (ESMO) 2023. The results demonstrate a manageable safety profile and early signs of durability of adagrasib
8-K
EX-99.1
n1w0trw
6 Jun 23
Other Events
8:08am
8-K
EX-99.1
it7wz4ngcuz20wdy1
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
4uw7rhgw66sjg
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
8-K
EX-99.1
m1f72pi6e4 uqzb
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
ux6 q20eqwuzi
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
iaeampeqt5h
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.1
d1mv8 o9lph
6 Jan 22
Zai Lab Announces NDA Acceptance of
7:44am
8-K
EX-99.1
tjgg kka15hprmq7db
9 Aug 21
Zai Lab Announces Second Quarter 2021
4:06pm
8-K
EX-99.1
idre5z8
31 Mar 21
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal
7:32am
8-K
EX-99.1
naiz6i1
1 Mar 21
Zai Lab Announces Financial Results
7:01am
10-K
tcp86m 8ozy75o8puiz
1 Mar 21
Annual report
12:00am